Marilyn Leitch

Author PubWeight™ 24.08^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Whole-genome analysis informs breast cancer response to aromatase inhibition.	Nature	2012	8.03
2	Circulating tumor cells in patients with breast cancer dormancy.	Clin Cancer Res	2004	4.48
3	HER-2 gene amplification can be acquired as breast cancer progresses.	Proc Natl Acad Sci U S A	2004	3.43
4	Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 breast cancer: clinical and biomarker outcomes and predictive value of the baseline PAM50-based intrinsic subtype--ACOSOG Z1031.	J Clin Oncol	2011	2.71
5	Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005).	J Natl Cancer Inst	2008	1.91
6	uPAR and HER-2 gene status in individual breast cancer cells from blood and tissues.	Proc Natl Acad Sci U S A	2006	1.61
7	A report on accrual rates for elderly and minority-ethnicity cancer patients to clinical trials of the American College of Surgeons Oncology Group.	J Am Coll Surg	2004	1.05
8	Outcomes of delays in time to treatment in triple negative breast cancer.	Ann Surg Oncol	2013	0.85
9	Identification of breast cancer DNA methylation markers optimized for fine-needle aspiration samples.	Cancer Epidemiol Biomarkers Prev	2013	0.77
10	A randomised trial of nursing interventions supporting recovery of the postmastectomy patient.	J Clin Nurs	2012	0.75
11	Primary breast tumor characteristics predicting aggressive nodal involvement.	Am J Surg	2007	0.75